Cellular and molecular neurosurgery: Pathways from concept to reality - Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system

Neurosurgery

Volumn 40, Issue 4, 1997, Pages 805-813

  Zlokovic, Berislav V ^a,b   Apuzzo, Michael L J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RMR 506 ^*  (United States)

Author keywords

Blood Brain barrier; Brain tumors; Gene therapy; Molecular neurosurgery; Neurodegenerative disorders; Stereotaxy; Stroke

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; LIPOSOME; LOBRADIMIL; VASOACTIVE AGENT; VIRUS VECTOR;

ADENOVIRUS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; EXPRESSION VECTOR; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; NERVE CELL; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; STEREOTAXIC SURGERY;

ANIMALS; BLOOD-BRAIN BARRIER; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS; INJECTIONS, INTRAVENTRICULAR; LIPOSOMES; NEUROSURGERY; STEM CELL TRANSPLANTATION; STEREOTAXIC TECHNIQUES; TRANSGENES; VIRAL PHYSIOLOGY; VIRUSES;

EID: 0030937038     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199704000-00028     Document Type: Review

References (51)

1. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Perricaudet M, Kahn A, Leschanski MR: Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 3:224-228, 1988.
2. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A: Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet 3:229-234, 1993.
3. Barnett PA, Roman-Goldstein S, Ramsey F, McCormick CI, Sexton G, Szumowski J, Neuwelt EA: Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat. Am J Pathol 146:436-449, 1995.
4. Bartus RT, Elliott P, Hayward N, Dean R, McEwne EL, Fisher SK: Permeability of the BBB by the bradykinin agonist, RMP-7: Evidence for a sensitive, autoregulated, receptor-mediated system. Immunopharmacology (in press).
5. Betz AL, Yang G-Y, Davidson BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15:547-551, 1995.
6. Breakefield XO, DeLuca NA: Herpes simplex virus for gene delivery to neurons. N Biol 3:203-218, 1991.
7. Brough DE, Lizonova A, Hsu C, Kulesa VA, Kovesdi T: A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol 70:6497-6501, 1996.
8. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-produced cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992.
9. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ: A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 3:219-223, 1993.
10. Davis AA, Temple S: A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 372:263-266, 1994.
11. Davson H, Zlokovic BV, Rakic L, Segal MB: Introduction to the Blood-Brain Barrier. London, Macmillan Press, 1993, pp 1-55.
12. Doran SE, Ren XD, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL: Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 36:965-970, 1995.
13. During MJ, Naegele JR, O'Malley KL, Geller AI: Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403, 1994.
14. Federoff HJ, Geschwind MD, Geller AI, Kessler JA: Expression of NGF in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic neurons. Proc Natl Acad Sci U S A 89:1636-1640, 1992.
15. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM: Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11-22, 1996.
16. Geller AI, Breakefield XO: A defective HSV-1 vector expresses Escherichia coli galactosidase in cultured peripheral neurons. Science 241:1667-1669, 1988.
17. Geller AI, During MJ, Jaycock JW, Freese A, Neve R: Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc Natl Acad Sci U S A 90:7603-7607, 1993.
18. Glorioso JC, DeLuca NA, Fink DJ: Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol 49:675-710, 1995.
19. Gordon EM, Anderson WF: Gene therapy using retroviral vectors. Curr Opin Biotech 5:611-616, 1994.
20. Ho DY, Mocarski ES, Sapolsky RM: Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci U S A 90:3655-3659, 1993.
21. Jiao S, Gurevich V, Wolff JA: Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362:450-453, 1993.
22. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154, 1994.
23. Latchman DS: Herpes simplex virus vectors for gene therapy. Mol Biotechnol 2:179-195, 1994.
24. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J: An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990, 1993.
25. LeMay DR, Kittaka M, Gordon EM Anderson WF, McComb JG, Weiss MH, Bartus R, Zlokovic BV: RMP-7 effect and the role of the blood brain barrier on ganciclovir treatment in a rat model of C6 glioma transduced with herpes thymidine kinase gene. Presented at the 46th Annual Meeting of the Congress of Neurological Surgeons, Montreal, Canada. September 28-October 3, 1996 (abstr).
26. Lundberg C, Horellou P, Mallet J, Bjorklund A: Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro characterization and in vivo effects in the rat Parkinson model. Exp Neurol 139:39-53, 1996.
27. Martinez-Serrano A, Lundberg C, Horellou P, Fischer W, Bentlage C, Campbell K, McKay RD, Mallet J, Bjorklund A: CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J Neurosci 15: 5668-5680, 1995.
28. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854-856, 1991.
29. Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL: Enhanced tumor uptake of carboplatin and survival in gliomabearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:125-134, 1996.
30. McComb JG, Zlokovic BV: Cerebrospinal fluid and the blood-brain interface, in Cheek WR, Marlin AE, McLone DG, Reigel DH, Walker ML (eds): Pediatric Neurosurgery. Philadelphia, W.B. Saunders Co., 1994, pp 167-185.
31. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I: Efficient generation of recombinant adenovirus using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324, 1996.
32. Neuwelt EA, Pagel MA, Geller A, Muldoon LL: Gene replacement therapy in the central nervous system: Viral vector-mediated therapy of global neurodegenerative disease. Behav Brain Sci 18:1-9, 1995.
33. Ono T, Fujino Y, Tsuchiya T, Tsuda M: Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci Lett 117:259-263, 1990.
34. Pincus DW, Harrison C, Barry J, Goodman RR, Labar D, Fraser RAR, Nedergaard M, Goldman SA: In vitro generation of precursor-derived neurons from adult human epileptic temporal neocortex. Presented at the 46th Annual Meeting of the Congress of Neurological Surgeons, Montreal, Canada. September 28-October 2, 1996 (abstr).
35. Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH: Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 79:400-407, 1993.
36. Rapoport SI, Hori M, Klatzo I: Reversible osmotic opening of the blood-brain barrier. Science 173:1026-1028, 1971.
37. Robinson PJ, Rapoport SI: Size selectivity of blood-brain barrier permeability at various times after osmotic opening. Am J Physiol 253:R459-R466, 1987.
38. Roessler BJ, Davidson BL: Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neurosci Lett 167:5-10, 1994.
39. Russell DW, Berger MS, Miller AD: The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 6:635-641, 1995.
40. Salmons B, Gunzber WH: Targeting of retroviral vectors for gene therapy. Hum Gene Ther 4:129-141, 1993.
41. Stemple DL, Anderson DJ: Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71:973-985, 1992.
42. Tenenbaum L, Darling JL, Hooghe-Peters E: Adeno-associated virus (AAV) as a vector for gene transfer into glial cells of the human central nervous system. Gene Ther 1[Suppl 1]:S80, 1994.
43. Vincent AJPE, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJJ, Vecht C, Bekkum DWV, Valerio D, Bout A, Hoogerbrugge PM: Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 7:197-205, 1996.
44. Viola JJ, Ram Z, Walbridge S, Oshiro EM, Trapnell B, Tao-Cheng JH, Oldfield EH: Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 82:70-76, 1995.
45. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Bjorklund A, Lindvall O, Langston JW: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phyenl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563, 1992.
46. Wolfe JH, Deshmane SL, Fraser NW: Herpesvirus vector gene transfer and expression of beta glucuronidase in the central nervous system of MPS VII mice. Nat Genet 1:379-384, 1992.
47. Wu P, de Fiebre CM, Millard WJ, King WA, Wang S, Bryant SO, Gao YP, Martin EJ, Mayer EM: An AAV promoter-driven neuropeptide Y gene delivery system using Sendai virosomes for neurons and rat brain. Gene Ther 3:246-253, 1996.
48. Zhang RD, Price JE, Fujimaki T, Bucana CD, Fidler IJ: Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am J Pathol 141:1115-1124, 1992.
49. Zhu N, Liggitt D, Liu Y, Debs R: Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211, 1993.
50. Zlokovic BV: Cerebrovascular permeability to peptides: Manipulations of transport systems at the blood-brain barrier. Pharm Res 12:1395-1406, 1995.
51. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: Pathways from concept to reality - Part I: Targets and concept approaches in gene therapy of the central nervous system. Neurosurgery 40:789-804, 1997.